Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 18, 2023

SELL
$191.51 - $216.16 $4,787 - $5,404
-25 Reduced 65.79%
13 $2,000
Q2 2023

Jul 25, 2023

BUY
$187.64 - $206.25 $187 - $206
1 Added 2.7%
38 $7,000
Q4 2022

Jan 10, 2023

BUY
$117.37 - $139.17 $821 - $974
7 Added 23.33%
37 $5,000
Q3 2022

Oct 13, 2022

SELL
$135.27 - $180.11 $5,275 - $7,024
-39 Reduced 56.52%
30 $4,000
Q4 2021

Feb 09, 2022

BUY
$142.57 - $190.86 $9,837 - $13,169
69 New
69 $11,000

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Umb Bank, N.A. Portfolio

Follow Umb Bank, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Umb Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Umb Bank, N.A. with notifications on news.